“Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease,” the researchers noted. The study is more …
Bengaluru: Richard Slayman, a 62-year-old man who made history as the first recipient of a genetically modified pig kidney, has died two months after the groundbreaking transplant. Massachusetts General Hospital, which …
New Delhi: The blockbuster diabetes and obesity drug semaglutide, developed by Danish pharma giant Novo Nordisk, has already emerged as a favourite among affluent sections of society in India and …